Literature DB >> 30298904

TGF-β suppresses RasGRP1 expression and supports regulatory T cell resistance against p53-induced CD28-dependent T-cell apoptosis.

Mariko Takami1,2,3, Christina Cunha1, Shinichiro Motohashi3, Toshinori Nakayama4, Makio Iwashima1,2.   

Abstract

Thymus-derived regulatory T cells (tTregs) play pivotal roles in immunological self-tolerance and homeostasis. A majority of tTregs are reactive to self-antigens and are constantly exposed to antigenic stimulation. Despite this continuous stimulation, tTreg and conventional T-cell populations remain balanced during homeostasis, but the mechanisms controlling this balance are unknown. We previously reported a form of activation-induced cell death, which is dependent on p53 (p53-induced CD28-dependent T-cell apoptosis, PICA). Under PICA-inducing conditions, tTregs survive while a majority of conventional T cells undergo apoptosis, suggesting there is a survival mechanism that protects tTregs. Here, we report that the expression of RasGRP1 (Ras guanyl-releasing protein 1) is required for PICA, as conventional T cells isolated from RasGRP1-deficient mice become resistant to PICA. After continuous stimulation, tTregs express a substantially lower amount of RasGRP1 compared to conventional T cells. This reduced expression of RasGRP1 is dependent on TGF-β, as addition of TGF-β to conventional T cells reduces RasGRP1 expression. Conversely, RasGRP1 expression in tTregs increases when TGF-β signaling is inhibited. Together, these data show that RasGRP1 expression is repressed in tTregs by TGF-β signaling and suggests that reduced RasGRP1 expression is critical for tTregs to resist apoptosis caused by continuous antigen exposure.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Foxp3; RasGRP1; TCR; TGF-β; Tregs

Mesh:

Substances:

Year:  2018        PMID: 30298904      PMCID: PMC6368088          DOI: 10.1002/eji.201847587

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  33 in total

1.  Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms.

Authors:  Ming O Li; Shomyseh Sanjabi; Richard A Flavell
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

2.  GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade.

Authors:  Tessa Gargett; Wenbo Yu; Gianpietro Dotti; Eric S Yvon; Susan N Christo; John D Hayball; Ian D Lewis; Malcolm K Brenner; Michael P Brown
Journal:  Mol Ther       Date:  2016-03-29       Impact factor: 11.454

3.  CD4(+)CD25(+) regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis.

Authors:  Nagendra Singh; Mutsumi Yamamoto; Mariko Takami; Yoichi Seki; Mayuko Takezaki; Andrew L Mellor; Makio Iwashima
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

4.  Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms.

Authors:  F E Fox; H C Ford; R Douglas; S Cherian; P C Nowell
Journal:  Cell Immunol       Date:  1993-08       Impact factor: 4.868

5.  A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Yongzhong Liu; Pin Zhang; Jun Li; Ashok B Kulkarni; Sylvain Perruche; Wanjun Chen
Journal:  Nat Immunol       Date:  2008-04-27       Impact factor: 25.606

6.  Excessive Th1 responses due to the absence of TGF-β signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis.

Authors:  Harumichi Ishigame; Lauren A Zenewicz; Shomyseh Sanjabi; Paula Licona-Limón; Maki Nakayama; Warren J Leonard; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

7.  Equol Induces Mitochondria-Dependent Apoptosis in Human Gastric Cancer Cells via the Sustained Activation of ERK1/2 Pathway.

Authors:  Zhiping Yang; Yan Zhao; Yahong Yao; Jun Li; Wangshi Wang; Xiaonan Wu
Journal:  Mol Cells       Date:  2016-10-31       Impact factor: 5.034

8.  TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function.

Authors:  D R Principe; A M Diaz; C Torres; R J Mangan; B DeCant; R McKinney; M-S Tsao; A Lowy; H G Munshi; B Jung; P J Grippo
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

Review 9.  GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing.

Authors:  Liping Sun; Hao Jin; Hui Li
Journal:  Oncotarget       Date:  2016-07-05

10.  CART cells are prone to Fas- and DR5-mediated cell death.

Authors:  Benjamin O Tschumi; Nina Dumauthioz; Bastien Marti; Lianjun Zhang; Evripidis Lanitis; Melita Irving; Pascal Schneider; Jean-Pierre Mach; Pedro Romero; Alena Donda
Journal:  J Immunother Cancer       Date:  2018-07-13       Impact factor: 13.751

View more
  1 in total

1.  Novel tumour suppressor roles for GZMA and RASGRP1 in Theileria annulata-transformed macrophages and human B lymphoma cells.

Authors:  Zineb Rchiad; Malak Haidar; Hifzur Rahman Ansari; Shahin Tajeri; Sara Mfarrej; Fathia Ben Rached; Abhinav Kaushik; Gordon Langsley; Arnab Pain
Journal:  Cell Microbiol       Date:  2020-09-29       Impact factor: 3.715

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.